Zobrazeno 1 - 10
of 176
pro vyhledávání: '"M. Michael Wolfe"'
Publikováno v:
Obesity. 31:1499-1504
Publikováno v:
Journal of Clinical Gastroenterology. 54:50-54
Goals We aimed to establish the epidemiological characteristics and documentation of diagnostic workup for gastroparesis (GP). Background No study has used a national database to evaluate the prevalence, demographics, and associated comorbid conditio
Publikováno v:
Digestive Diseases and Sciences. 64:158-166
Proton pump inhibitors (PPIs) are potent inhibitors of acid secretion and are the mainstay of therapy for gastroesophageal reflux disease (GERD). Initially designed to be taken 30 min before the first daily meal, these agents are commonly used subopt
Publikováno v:
American Journal of Physiology-Endocrinology and Metabolism. 309:E1008-E1018
Previous reports have suggested that the abrogation of gastric inhibitory polypeptide (GIP) signaling could be exploited to prevent and treat obesity and obesity-related disorders in humans. This study was designed to determine whether immunoneutrali
Publikováno v:
Peptides. 125:170227
Gastric inhibitory polypeptide (GIP) is a regulatory peptide expressed in the mammalian upper small intestine, and both GIP and its receptor (GIPR) are expressed in the cortex and hippocampus regions of the brain as well. While learning and memory de
Publikováno v:
American Journal of Gastroenterology. 109:789-794
Optimal administration of proton pump inhibitor (PPI) for the treatment of gastroesophageal reflux disease (GERD) requires consideration of meal timing. Since becoming available over the counter (OTC), no studies have assessed treatment patterns and
Autor:
M. Michael Wolfe, Debora S. Bruno
Publikováno v:
Adipocytokines, Energy Balance, and Cancer ISBN: 9783319416755
Beyond its role in nutrient absorption, the gastrointestinal tract is a vital endocrine organ responsible for the production of a variety of regulatory peptides that modulate energy balance. In this chapter, the most studied gastrointestinal peptides
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4a6e5e3b5633ab805fa75547119347ae
https://doi.org/10.1007/978-3-319-41677-9_11
https://doi.org/10.1007/978-3-319-41677-9_11
Publikováno v:
Regulatory Peptides. 171:26-34
Glucose-dependent insulinotropic polypeptide (GIP) is a mammalian incretin hormone released into the circulation following nutrient ingestion. We examined the functional evolution of GIP and its relationship with insulin to delineate their respective
Publikováno v:
Regulatory Peptides. 164:97-104
Glucose-dependent insulinotropic polypeptide (GIP), an important component of the enteroinsular axis, is a potent stimulator of insulin secretion, functioning to maintain nutrient efficiency. Although well-characterized in mammals, little is known re
Glucose-dependent insulinotropic polypeptide stimulates the proliferation of colorectal cancer cells
Autor:
Daniel Prabakaran, Joseph D. Feuerstein, Baogui Wang, Priti Bijpuria, Jennifer A. Sinclair, M. Michael Wolfe, Lisa I. Jepeal
Publikováno v:
Regulatory Peptides. 163:74-80
Although numerous epidemiological studies have provided convincing evidence for an increase in the prevalence of colorectal cancer (CRC) in obese individuals, the precise mechanisms involved have not been elucidated. Glucose-dependent insulinotropic